Page 92 - 78_04
P. 92
M.
MALIK
&
col
7. World
Health
Organization,
How
to
Investigate
Drug
Use
in
Health
Facilities:
Selected
Drug
Use
Indicators:
Action
Programme
on
Essential
Drugs
1993:
World
Health
Organization.
8. Ghaffar,
A.,
Kazi,
B.M.
and
Salman,
M.
(2000)
Health
care
systems
in
transition
III.
Pakistan,
Part
I.
An
overview
of
the
health
care
system
in
Pakistan.
Journal
of
Public
Health,
22(1):
38--42
9. Rational
Pharmaceutical
Management
Plus
Program,
Pharmaceutical
Management
for
Malaria,
USAD,
Editor
2004,
U.S.
Agency
for
International
Development:
USA.
10. Obinna,
O.,
Kaur,H.,
Dike,
E.,
Shu,E.,
Uzochukwu,B.,
Hanson,K.,
Okoye,V.
and
Okonkwo,P.
et
al.,
(2009).
Malaria
treatment
perceptions,
practices
and
influences
on
provider
behaviour:
comparing
hospitals
and
non--hospitals
in
south--east
Nigeria.
Mal.,J.,
8:
246--.
doi:10.1186/1475--2875--8--22
11. Chitaka,
R.,.
Khare,
A.K
and
Brickling,
C.
(1998).
Prescribing
policy
for
antimalarials.
.
African
Health,
20(2):
2--5.
12. Das,
N.,
Baloch
H.
Khan,
A.
NBadini,
Z.
A.
Parkash,J.
et
al.,
(2001).
Prescribing
practices
of
consultants
at
Karachi,
Pakistan.
Journal--Pakistan
Medical
Association,
51(2):
74--77.
13. Elhassan,
A.M.S.A.(1999).
Prescribing
and
dispensing
practice
at
NGO,
govemment.and
private
clinics
in
Nepalguni
municipality.
Nepal
INRUD
News
9:
25--26.
14. Igboeli,
N.U.,
Ukwe,
C.V.
and
Ekwunife,
O.I.
(2010).
Increasing
use
of
artemisinin--based
combination
therapy
for
treatment
of
malaria
infection
in
Nigerian
hospitals.
Pharmacy
Practice
(Internet),
8(4):
243--249.
15. Yousif,
M.A.
and
Adeel,
A.A.
(2000).
Antimalarials
prescribing
patterns
in
Gezira
State:
precepts
and
practices.
Eastern
Mediterranean
Health
Journal,
15(5/6):.
939--947.
16. Adibe,
M.O.(2010).
Predictors
to
adherence
to
national
anti--malarial
treatment
guidelines
in
some
Nigerian
hospitals.
Inter.J
Drug
Development
and
Research,
2(3):
545--554.
510